Pacific Plate

Arthrex Receives FDA Clearance for TightRope® Implant as First, Only Device Cleared for Pediatric ACL Surgery

Retrieved on: 
Tuesday, January 10, 2023

NAPLES, Fla., Jan. 10, 2023 /PRNewswire/ -- Arthrex, a global leader in minimally invasive surgical technology, announced today its ACL TightRope implant has received clearance from the U.S. Food and Drug Administration (FDA) for pediatric indications. The TightRope implant is used in the surgical treatment of orthopedic injuries and is the first and only fixation device for anterior cruciate ligament (ACL) injuries cleared for pediatric use.

Key Points: 
  • The TightRope implant is used in the surgical treatment of orthopedic injuries and is the first and only fixation device for anterior cruciate ligament (ACL) injuries cleared for pediatric use.
  • Cordasco and Green helped Arthrex develop pediatric and young adolescent-specific instrumentation guides to address a growing population of young athletes facing ACL injuries.
  • The Arthrex all-epiphyseal technique was developed for skeletally immature patients and involves avoiding the pediatric growth plates to repair or reconstruct the ACL.
  • The Arthrex ACL TightRope portfolio of fixation devices includes the ACL TightRope II implant, the TightRope attachable button system (ABS) and implant, the FiberTag® TightRope implant and the ACL Repair TightRope implant with FiberRing™ sutures.

Turner Imaging Systems’ SMART-C ® Humanitarian Mission in Liberia

Retrieved on: 
Wednesday, January 4, 2023

Turner Imaging Systems, a leader in advanced X-ray imaging technologies, has partnered with LifeBridge Sinai Hospital in Baltimore to provide a SMART-C® mini C-arm system for a humanitarian mission in Liberia.

Key Points: 
  • Turner Imaging Systems, a leader in advanced X-ray imaging technologies, has partnered with LifeBridge Sinai Hospital in Baltimore to provide a SMART-C® mini C-arm system for a humanitarian mission in Liberia.
  • “For one young patient, the team performed guided growth, which was never before attempted in Liberia.
  • Turner Imaging Systems CEO and Founder, Dr. D. Clark Turner stated: “Humanitarian service work is at the core of Turner Imaging's mission.
  • To learn more about our mission support in Liberia, read our customer story .

WHAT'S NEW: 2023 Lexus IS 300/350/500

Retrieved on: 
Wednesday, September 14, 2022

With the launch of the all-new IS in 2021, Lexus expanded on that legacy by sharpening the driving performance fundamentals through the introduction of Lexus Driving Signature, a key pillar for the Lexus brand.

Key Points: 
  • With the launch of the all-new IS in 2021, Lexus expanded on that legacy by sharpening the driving performance fundamentals through the introduction of Lexus Driving Signature, a key pillar for the Lexus brand.
  • For 2023, the IS 350 will be offered in a new F SPORT Design grade for both RWD and AWD configurations.
  • Lexus Driving Signature is a key pillar of the Lexus Next Chapter and represents a fundamental shift in our product development process and culture.
  • The 2023 IS comes standard with Lexus Safety System+ 2.5, which brings a suite of key active safety features to the vehicle.

Today's Podiatrist Keeps Kids Active

Retrieved on: 
Tuesday, April 5, 2022

BETHESDA, Md., April 5, 2022 /PRNewswire/ -- America's podiatrists want parents to know that foot and ankle pain is never normal for kids. If a child experiences pain or a change in the condition of their feet and ankles, it's time to check in with the expert in kids' foot health—today's podiatrist.

Key Points: 
  • BETHESDA, Md., April 5, 2022 /PRNewswire/ -- America's podiatrists want parents to know that foot and ankle pain is never normal for kids.
  • If a child experiences pain or a change in the condition of their feet and ankles, it's time to check in with the expert in kids' foot healthtoday's podiatrist.
  • The Today's Podiatrist Keeps Kids Active campaign is designed to educate parents about how to keep their children's feet and ankles healthy and when to seek care from a podiatrist to ensure children can stay active.
  • Podiatrists say some of the most common conditions to watch for in kids are:
    ApophysitisIf a young athlete complains of persistent heel pain, it's time to see a podiatrist.

Inozyme Pharma Announces Presentation of Data from ENPP1 Deficiency Development Program at the ASBMR 2021 Annual Meeting

Retrieved on: 
Monday, October 4, 2021

BOSTON, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY), a rare disease biopharmaceutical company developing novel therapeutics for the treatment of abnormal mineralization, today announced the presentation of data from the Company’s ENPP1 Deficiency Natural History Study and its gene therapy program for the treatment of ENPP1 Deficiency. The data were presented at the American Society for Bone and Mineral Research (ASBMR) 2021 Annual Meeting held October 1-4.

Key Points: 
  • The data were presented at the American Society for Bone and Mineral Research (ASBMR) 2021 Annual Meeting held October 1-4.
  • ENPP1 Deficiency is a progressive condition that manifests as a spectrum of disease.
  • These data highlight implications for the appropriate diagnosis and treatment of patients with ENPP1 Deficiency.
  • Inozyme is developing INZ-701 for certain rare, life-threatening, and devastating genetic disorders such as ENPP1 Deficiency and ABCC6 Deficiency in which PPi levels are below the normal physiological levels.